Antitrust implications of medical technology assessment.
Rose
M
M
Leibenluft
R F
RF
D003363:Cost Control; D004465:Economic Competition / Q000331:legislation & jurisprudence; D007348:Insurance, Health / Q000331:legislation & jurisprudence; D009316:National Institutes of Health (U.S.); D013673:Technology Assessment, Biomedical / Q000191:economics / Q000331:legislation & jurisprudence*; D014481:United States; D014485:United States Federal Trade Commission